Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors
Authors:
Open Access
- 25 March 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-14
Abstract
Alzheimer’s disease (AD) is the most common type of age-related dementia. Inhibition of butyrylcholinesterase (BChE) emerge as an effective therapeutic target for AD. A series of new substituted acetamide derivatives were designed, synthesized and evaluated for their ability to inhibit BChE. The bioassay results revealed that several compounds displayed attractive inhibition against BChE). Among them, compound 8c exhibited the highest BChE inhibition with IC50 values of 3.94 μM. Lineweaver Burk plot indicated that 8c acted as a mixed-type BChE inhibitor. In addition, docking studies confirmed the results obtained through in vitro experiments, and showed that 8c bound to the catalytic anionic site (CAS) and peripheral anionic site (PAS) of BChE active site. Meanwhile, its ADME parameters were approximated using in silico method. Molecular dynamics simulation studies on the complex of 8c-BChE were performed, RMSD, RMSF, Rg, SASA, and the number of hydrogen bonds were calculated as well. These results implied that 8c could serve as appropriate lead molecule for the development of BChE inhibitor.Keywords
Funding Information
- The Open Project of Central Nervous System Drug Key Laboratory of Sichuan Province (210018-01SZ)
This publication has 29 references indexed in Scilit:
- Probing the Peripheral Site of Human ButyrylcholinesteraseBiochemistry, 2012
- Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in miceBehavioural Brain Research, 2011
- The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase DeficiencyThe Journal of Pharmacology and Experimental Therapeutics, 2008
- A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of IndiaClinica Chimica Acta, 2007
- Medicinal chemical properties of successful central nervous system drugsNeuroRX, 2005
- On the Importance of Atomic Fluctuations, Protein Flexibility, and Solvent in Ion PermeationJournal of General Physiology, 2004
- Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamusJournal of Comparative Neurology, 2003
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitorsBiochemistry, 1993
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934